Altered Cell Modalities: Cancer Treatments and Nursing Management

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/23

flashcard set

Earn XP

Description and Tags

A comprehensive vocabulary review of cancer treatment modalities, chemotherapy classifications, radiation safety protocols, and oncologic nursing interventions.

24 Terms

1
New cards

Curative Therapy

A cancer treatment goal focused on completely eliminating or curing the disease.

2
New cards

Control Therapy

A treatment goal aimed at slowing disease growth, stopping the spread, and stabilizing the cancer.

3
New cards

Palliative Therapy

A treatment approach designed to relieve pain, physical symptoms, and stress to promote comfort rather than curing the disease.

4
New cards

Biotherapy

A cancer treatment modality that uses substances derived from living organisms to fight disease, regulate immune responses, or target specific cells.

5
New cards

Teletherapy

External beam radiation therapy where the radiation source is outside the body; utilizes tattoo markings for beam alignment, and neither the patient nor their body excreta is radioactive.

6
New cards

Brachytherapy

Internal radiation therapy delivered via sealed implanted radioactive seeds or unsealed radioactive isotopes administered into the body.

7
New cards

Sealed Radiation

A form of internal radiation therapy where the radioactive source is implanted very near or within the tumor, making the patient radioactive while the implant remains in place.

8
New cards

Unsealed Radiation

A form of internal radiation where the isotope is administered orally, intracavitary, or intravenously, causing both the patient and their bodily excreta to be radioactive.

9
New cards

Dosimeter Badge

A personal radiation monitoring device that healthcare workers must wear at all times to measure occupational radiation exposure when caring for patients undergoing implant radiation therapy.

10
New cards

Radiation Implant Safety Precautions

Safety parameters requiring healthcare staff and visitors to limit visits to under 12 hr\frac{1}{2}\,\text{hr}, stay at least 6 ft6\,\text{ft} away, avoid pregnant caregivers, and use long-handled forceps to handle dislodged radioactive elements into a lead container.

11
New cards

Total Body Surface Area (TBSA)

The clinical measurement index used to calculate and individualize dosage regimens for chemotherapy administration.

12
New cards

Alkylating Agents

Cell cycle non-specific chemotherapy agents (e.g., Cyclophosphamide, Cisplatin, Busulfan, Chlorambucil) that interfere with DNA synthesis and replication, known to cause general bone marrow suppression and specific bladder, kidney, and nerve damage.

13
New cards

Antimetabolites

Cell cycle specific chemotherapy medications active in the S phase (e.g., Methotrexate, 5FU, Cytarabine) that disrupt DNA and RNA synthesis in rapidly dividing cells.

14
New cards

Anti-Tumor Antibiotics

Cell cycle non-specific cytotoxic drugs (e.g., Doxorubicin, Bleomycin, Mitomycin) that bind cellular DNA and inhibit DNA and RNA synthesis by breaking the helix, carrying specific cardio, pulmonary, and hepatic toxicities.

15
New cards

Antimitotics

Cell cycle specific chemotherapy agents active in the M phase (e.g., Vincristine, Vinblastine, Paclitaxel) that frequently act as vesicants and carry high risks of hypersensitivity and neurotoxicity.

16
New cards

Topoisomerase 1 Inhibitors

Cell cycle specific chemotherapy agents active in the S phase (e.g., Irinotecan, Topotecan) that disrupt DNA topoisomerase enzymes that manage the winding, supercoiling, and tangling of DNA.

17
New cards

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

A neurotoxic adverse effect of chemotherapy affecting 30%−40%30\%-40\% of patients, characterized by numbness, tingling, stabbing pain, weakness, and loss of sensation in the extremities.

18
New cards

Stomatitis / Mucositis

Erythema, soreness, and ulceration of the oral mucosa caused by cancer therapy; managed with soft toothbrushes, avoidance of flossing, topical analgesics, water-based moisturizers, and avoidance of commercial mouthwashes.

19
New cards

Low Bacteria Diet

A dietary intervention for neutropenic oncology patients that strictly eliminates raw fruits, raw vegetables, and partially cooked meats to minimize infectious foodborne exposures.

20
New cards

Filgrastim (Neupogen)

A colony-stimulating factor prescribed to accelerate neutrophil recovery and increase white blood cell counts in neutropenic patients; commonly causes bone pain.

21
New cards

Erythropoietin (Epogen, Procrit)

A colony-stimulating factor that stimulates red blood cell production to treat therapy-related anemia in cancer patients.

22
New cards

Monoclonal Antibodies (MAB)

Targeted biologic response modifiers that attach to specific cellular markers, including Trastuzumab (Herceptin) for breast cancer, Rituximab (Rituxan) for non-Hodgkin's lymphoma, and Bevacizumab (Avastin) to inhibit tumor vascularization.

23
New cards

Sipuleucel-T (Provenge®)

An FDA-approved therapeutic cancer vaccine designed to induce an active cellular immune response for the treatment of prostate cancer.

24
New cards

Complementary & Alternative Medicine (CAM)

Non-conventional health practices and products not traditionally considered standard oncology care, utilized by 50%50\% of cancer patients and representing over $34 billion\$34\,\text{billion} in annual spending.